Stroke News

Cancer survivors with the lowest socioeconomic status appeared twice as likely to die of CVD than those with the highest household incomes, according to a study published in European Heart Journal – Quality of Care and Clinical Outcomes.

Adults with obstructive sleep apnea had elevated odds of developing various heart-related health conditions compared with those without it, and the association was strongest in younger individuals, researchers reported.

Patient sex had seemingly no effect on the safety and efficacy of aspirin for patients with atherosclerotic CVD, according to secondary analysis of the ADAPTABLE trial published in JAMA Cardiology.

Statin initiation in patients with stroke etiologies not indicated for secondary prevention with statin therapy could hypothetically cause thousands of adverse events every year, according to a new meta-analysis published in Stroke.

Women with type 2 diabetes diagnosed with hypertension at younger than age 50 years have an increased risk for cardiovascular disease and could benefit from intensive antihypertension therapy according to data published in Diabetes Care.

Loneliness was associated with an increased risk for stroke in middle-aged and older adults, and the risk was particularly high among those with chronic loneliness, a study in eClinicalMedicine showed.

People with narcolepsy were more likely than propensity score-matched people without narcolepsy to develop heart disease, regardless of sleep apnea status, according to a retrospective cohort study.

Almost one-third of adults aged 60 years and older without CVD regularly used aspirin for primary prevention in 2021, contrary to guidance from medical organizations, a study showed.

Reflecting disparities in cardiovascular care, there were nearly 800,000 excess CV deaths among Black Americans between 2000 and 2022, according to a “report card” published in the Journal of the American College of Cardiology.

A system for mechanical thrombectomy treating ischemic stroke demonstrated a high level of sensitivity and specificity compared with human evaluation in a recent clinical trial, according to the manufacturer.